Summary

Executive Summary

According to Azoth Analytics research report, the Therapeutic Monoclonal Antibodies Market is projected to display significant growth represented by a CAGR of 18.63% during 2022–2028. The Global Therapeutic Monoclonal Antibodies Market was valued at USD 334.38 Billion in the year 2021 with the Americas region leading the regional market share.

The Therapeutic Monoclonal Antibodies market's demand has surged in the past year due to the increasing incidence of chronic diseases like cancer, autoimmune disorders, infectious diseases, Neurological and cardiovascular diseases.

America is the largest market for Therapeutic Monoclonal Antibodies with the U.S. accounting for a major share of the total Therapeutic Monoclonal Antibodies consumption in the region.

The European region is a lucrative market and is growing at an exponential rate during the forecast period owing to the rising prevalence of chronic diseases due to the large geriatric population as well as the developed healthcare infrastructure of countries like the United Kingdom and Germany.

Asia Pacific region is the fastest growing region owing to the rapid development and entry of major players in the APAC region and is anticipated to register the fastest growth during the forecast period.



Scope of the Report

• The report presents the analysis of the Therapeutic Monoclonal Antibodies Market for the forecast period of 2023-2028.

• The report analyses the Therapeutic Monoclonal Antibodies Market by Value (USD Billion).

• The report analyses the Therapeutic Monoclonal Antibodies By Source (Humanized, Murine, Chimeric, Human)

• The report analyses the Therapeutic Monoclonal Antibodies Market, By Target (Cell surface antigen, plasma protein or drug, Other Targets, infectious organism)

• The report analyses the Therapeutic Monoclonal Antibodies Market by Indication (Cancer, Infectious Disease, Autoimmune Disorders, Neurological Disorders, Other Indications).

• The report analyses the Therapeutic Monoclonal Antibodies Market by Route of Administration (Intravenous, Subcutaneous, Other ROA).

• The Global Therapeutic Monoclonal Antibodies Market has been analysed By Region (Americas, Europe, Asia Pacific, MEA).

• The Global Therapeutic Monoclonal Antibodies Market has been analysed By Country (United States, Canada, Germany, U.K, France, Spain, Italy, China, Japan, India).

• The key insights of the report have been presented through the leading company shares. Also, the attractiveness of the market has been presented by region, by Source, by Target, by Indication, by route of administration

• Also, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.

• The report tracks competitive developments, strategies, and recent developments. The companies analysed in the report include Eli Lily and Co., GSK plc, Roche, Astra Zenca plc, Bayer, Amgen, Johnson & Johnson, Pfizer, Novartis, Merck & Co.



Key Target Audience

• Pharmaceutical Companies

• Biotechnology Companies

• Government Bodies & Regulating Authorities

• Investment Banks and Equity Firms

ページTOPに戻る

Table of Contents

1. Introduction

1.1 Therapeutic Monoclonal Antibodies Market Overview

1.2 Scope of Research

2. Executive Summary

2.1 Market Snapshot

2.2 Regional Insights

2.3 Market Ecosystem Factors

3. Research Methodology

3.1 Data Collection Process

3.2 Market Trajectory Estimation

3.3 Market Size Calculation-Top-to-Bottom

4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Trends

4.5 Analyst Recommendations

4.6 Impact Analysis

5. Value Chain Analysis

6. COVID-19 Impact Assessment

6.1 Degree of Impact of COVID-19 on Therapeutic Monoclonal Antibodies Market

6.2 Region-Wise Quarterly Coved Impact Analysis (2020)

7. Porter's five forces analysis

8. Macro Economic Indicator Outlook

8.1 GDP per capita growth (annual %)

8.2 Global Medical Spending

8.3 Current Healthcare Expenditure

8.4 Pharmaceutical Spending/capita

9. Competitive Positioning

9.1 Companies’ Product Positioning

9.2 Market Position Matrix

9.3 Market Share Analysis of Therapeutic Monoclonal Antibodies Market

9.4 Company profiles

9.4.1 Eli-Lily & Co

9.4.2 GSK plc.

9.4.3 Bayer AG

9.4.4 Johnson & Johnson

9.4.5 Amgen

9.4.6 Astra Zeneca plc.

9.4.7 Novartis

9.4.8 Merck & Co., Inc.

9.4.9 Pfizer Inc.

9.4.10 Roche Holding AG

10. Global therapeutic monoclonal antibodies market

10.1 Impact Analysis of Macro Economic Factors on Therapeutic Monoclonal Antibodies Market

10.2 Market Size and CAGR

10.3 Global Therapeutic Monoclonal Antibodies Market: Market Value Assessment

10.4 Market Summary

11 Global Therapeutic Monoclonal Antibodies Market Trend and Forecast Analysis, 2018-2028, By Source

11.1 Global Therapeutic Monoclonal Antibodies Market Trend and Forecast Analysis, By Source: Snapshot

11.2 Humanized

11.3 Murine

11.4 Chimeric

11.5 Human

12. Global Therapeutic Monoclonal Antibodies Market Trend and Forecast Analysis, 2018-2028, By Target

12.1 Global Therapeutic Monoclonal Antibodies Market Trend and Forecast Analysis, By Target: Snapshot

12.2 Cell surface antigen

12.3 Plasma protein or drug

12.4 Infectious organism

12.5 Other Targets

13. Global Therapeutic Monoclonal Antibodies Market Trend and Forecast Analysis, 2018-2028, By Indication

13.1 Global Therapeutic Monoclonal Antibodies Market Trend and Forecast Analysis, By Indication: Snapshot

13.2 Cancer

13.3 Infectious Disease

13.4 Autoimmune Disorders

13.5 Neurological Disorders

13.6 Other Indications

14. Global Therapeutic Monoclonal Antibodies Market Trend and Forecast Analysis, 2018-2028, By Route of Administration

14.1 Global Therapeutic Monoclonal Antibodies Market Trend and Forecast Analysis, By Indication: Snapshot

14.2 Intravenous

14.3 Subcutaneous

14.4 Other ROA

15. Global Therapeutic Monoclonal Antibodies Market Trend and Forecast Analysis, 2018-2028, By Region

15.1 Regional Coverage of the Study

16. Americas Therapeutic Monoclonal Antibodies Market Trends and Forecast Analysis, 2018-2028, USD Million & CAGR

16.1 Macro Economic Factor Impact Index

16.2 Impact analysis of market dynamics on Therapeutic Monoclonal Antibodies Market

16.3 Americas Therapeutic Monoclonal Antibodies Market: Snapshot

16.4 Americas Therapeutic Monoclonal Antibodies Market Size, By Value, 2018-2028(USD Million)

16.5 Americas Therapeutic Monoclonal Antibodies Market Trend and Forecast Analysis: Segmentation

16.5.1 By Source

16.5.2 By Target

16.5.3 By Indication

16.5.4 By Route of Administration

16.5.5 By Country

16.5.5.1 United States

16.5.5.2 Canada

16.5.5.3 Brazil

17. Europe Therapeutic Monoclonal Antibodies Market Trends and Forecast Analysis, 2018-2028, USD Million & CAGR

17.1 Macro Economic Factor Impact Index

17.2 Impact analysis of market dynamics on Therapeutic Monoclonal Antibodies Market

17.3 Europe Therapeutic Monoclonal Antibodies Market: Snapshot

17.4 Europe Therapeutic Monoclonal Antibodies Market Size, By Value, 2018-2028(USD Million)

17.5 Europe Therapeutic Monoclonal Antibodies Market Trend and Forecast Analysis: Segmentation

17.5.1 By Source

17.5.2 By Target

17.5.3 By Indication

17.5.4 By Route of Administration

17.5.5 By Country

17.5.5.1 Germany

17.5.5.2 United Kingdom

17.5.5.3 France

17.5.5.4 Italy

17.5.5.5 Spain

17.5.5.6 Rest of Europe

18. Asia Pacific Therapeutic Monoclonal Antibodies Market Trends and Forecast Analysis, 2018-2028, USD Million & CAGR

18.1 Macro Economic Factor Impact Index

18.2 Impact analysis of market dynamics on Therapeutic Monoclonal Antibodies Market

18.3 Asia Pacific Therapeutic Monoclonal Antibodies Market: Snapshot

18.4 Asia Pacific Therapeutic Monoclonal Antibodies Market Size, By Value, 2018-2028(USD Million)

18.5 Asia Pacific Therapeutic Monoclonal Antibodies Market Trend and Forecast Analysis: Segmentation

18.5.1 By Source

18.5.2 By Target

18.5.3 By Indication

18.5.4 By Route of Administration

18.5.5 By Country

18.5.5.1 China

18.5.5.2 Japan

18.5.5.3 India

18.5.5.4 Rest of Asia Pacific

19. Middle East & Africa Therapeutic Monoclonal Antibodies Market Trends and Forecast Analysis, 2018-2028, USD Million & CAGR

19.1 Macro Economic Factor Impact Index

19.2 Impact analysis of market dynamics on Therapeutic Monoclonal Antibodies Market

19.3 Middle East & Africa Therapeutic Monoclonal Antibodies Market: Snapshot

19.4 Middle East Therapeutic Monoclonal Antibodies Market Size, By Value, 2018-2028(USD Million)

19.5 Middle East & Africa Therapeutic Monoclonal Antibodies Market Trend and Forecast Analysis: Segmentation

19.5.1 By Source

19.5.2 By Target

19.5.3 By Indication

19.5.4 By Route of Administration